☰

Marie Asberg - Publications

Affiliations: 
Karolinska Institute, Stockholm, Sweden 
Area:
Psychiatry
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Boström AED, Jamshidi E, Manu DM, Kular L, Schiöth HB, Åsberg M, Jokinen J. Epigenetic changes in the CYP2D6 gene are related to severity of suicide attempt: A cross-sectional study of suicide attempters. Journal of Psychiatric Research. 160: 217-224. PMID 36857986 DOI: 10.1016/j.jpsychires.2023.02.025  0.326
2023 Jamshidi E, Boström AED, Wilczek A, Nilsonne Å, Åsberg M, Jokinen J. Increased Methylation of Brain-Derived Neurotrophic Factor ( Is Related to Emotionally Unstable Personality Disorder and Severity of Suicide Attempt in Women. Cells. 12. PMID 36766691 DOI: 10.3390/cells12030350  0.365
2020 Rajalin M, Hirvikoski T, Renberg ES, Åsberg M, Jokinen J. Exposure to Early Life Adversity and Interpersonal Functioning in Attempted Suicide. Frontiers in Psychiatry. 11: 552514. PMID 33093835 DOI: 10.3389/Fpsyt.2020.552514  0.428
2018 Jokinen J, Bostrom A, Asberg M, Schioth H. Severity of Suicide Attempt is Associated With Epigenetic and Transcriptional Changes in the CYP2D6 Gene Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.960  0.35
2017 Bendix M, Uvnäs-Moberg K, Petersson M, Kaldo V, Åsberg M, Jokinen J. Insulin and glucagon in plasma and cerebrospinal fluid in suicide attempters and healthy controls. Psychoneuroendocrinology. 81: 1-7. PMID 28391069 DOI: 10.1016/J.Psyneuen.2017.03.019  0.364
2016 Rajalin M, Hirvikoski T, Salander Renberg E, Åsberg M, Jokinen J. Family history of suicide and interpersonal functioning in suicide attempters. Psychiatry Research. 247: 310-314. PMID 27951478 DOI: 10.1016/J.Psychres.2016.11.029  0.471
2016 Stefansson J, Chatzittofis A, Nordström P, Arver S, Åsberg M, Jokinen J. CSF and plasma testosterone in attempted suicide. Psychoneuroendocrinology. 74: 1-6. PMID 27567115 DOI: 10.1016/j.psyneuen.2016.08.009  0.389
2015 Stefansson J, Nordström P, Runeson B, Åsberg M, Jokinen J. Combining the Suicide Intent Scale and the Karolinska Interpersonal Violence Scale in suicide risk assessments. Bmc Psychiatry. 15: 226. PMID 26400812 DOI: 10.1186/s12888-015-0607-6  0.302
2014 Isung J, Aeinehband S, Mobarrez F, Nordström P, Runeson B, Asberg M, Piehl F, Jokinen J. High interleukin-6 and impulsivity: determining the role of endophenotypes in attempted suicide. Translational Psychiatry. 4: e470. PMID 25335166 DOI: 10.1038/tp.2014.113  0.333
2013 Chatzittofis A, Nordström P, Hellström C, Arver S, Ã…sberg M, Jokinen J. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1280-7. PMID 23453639 DOI: 10.1016/j.euroneuro.2013.02.002  0.391
2012 Wiklander M, Samuelsson M, Jokinen J, Nilsonne A, Wilczek A, Rylander G, Asberg M. Shame-proneness in attempted suicide patients. Bmc Psychiatry. 12: 50. PMID 22632273 DOI: 10.1186/1471-244X-12-50  0.39
2012 Jokinen J, Chatzittofis A, Hellström C, Nordström P, Uvnäs-Moberg K, Asberg M. Low CSF oxytocin reflects high intent in suicide attempters. Psychoneuroendocrinology. 37: 482-90. PMID 21852050 DOI: 10.1016/J.Psyneuen.2011.07.016  0.405
2011 Moberg T, Nordström P, Forslund K, Kristiansson M, Asberg M, Jokinen J. CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. Journal of Affective Disorders. 132: 173-8. PMID 21356560 DOI: 10.1016/j.jad.2011.01.018  0.401
2010 Jokinen J, Forslund K, Ahnemark E, Gustavsson JP, Nordström P, Asberg M. Karolinska Interpersonal Violence Scale predicts suicide in suicide attempters. The Journal of Clinical Psychiatry. 71: 1025-32. PMID 20797380 DOI: 10.4088/JCP.09m05944blu  0.329
2006 Lundbäck E, Forslund K, Rylander G, Jokinen J, Nordström P, Nordström AL, Asberg M. CSF 5-HIAA and the rorschach test in patients who have attempted suicide. Archives of Suicide Research : Official Journal of the International Academy For Suicide Research. 10: 339-45. PMID 16920684 DOI: 10.1080/13811110600790942  0.394
2004 Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjögren M, Asberg M, Ekman R, Wahlestedt C, Agren H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. Journal of Psychiatric Research. 38: 113-21. PMID 14757324 DOI: 10.1016/S0022-3956(03)00101-8  0.315
2004 Perseius K, Samuelsson M, Andersson E, Berndtsson T, Götmark H, Henriksson F, Kåver A, Nilsonne Å, Åsberg M. Does Dialectical Behavioural Therapy Reduce Treatment Costs for Patients with Borderline Personality Disorder. A Pilot Study Nordic Journal of Nursing Research. 24: 27-30. DOI: 10.1177/010740830402400206  0.32
2003 Runeson B, Asberg M. Family history of suicide among suicide victims. The American Journal of Psychiatry. 160: 1525-6. PMID 12900320  0.322
2001 Roy A, Rylander G, Forslund K, Asberg M, Mazzanti CM, Goldman D, Nielsen DA. Excess tryptophan hydroxylase 17 779C allele in surviving cotwins of monozygotic twin suicide victims. Neuropsychobiology. 43: 233-6. PMID 11340361 DOI: 10.1159/000054895  0.312
2000 Samuelsson M, Wiklander M, Asberg M, Saveman BI. Psychiatric care as seen by the attempted suicide patient. Journal of Advanced Nursing. 32: 635-43. PMID 11012806  0.338
2000 Lidberg L, Belfrage H, Bertilsson L, Evenden MM, Asberg M. Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders. Acta Psychiatrica Scandinavica. 101: 395-402. PMID 10823300  0.31
1998 Ferrada-Noli M, Asberg M, Ormstad K. Suicidal behavior after severe trauma. Part 2: The association between methods of torture and of suicidal ideation in posttraumatic stress disorder. Journal of Traumatic Stress. 11: 113-24. PMID 9479680 DOI: 10.1023/A:1024413301064  0.333
1998 Ferrada-Noli M, Asberg M, Ormstad K, Lundin T, Sundbom E. Suicidal behavior after severe trauma. Part 1: PTSD diagnoses, psychiatric comorbidity, and assessments of suicidal behavior. Journal of Traumatic Stress. 11: 103-12. PMID 9479679 DOI: 10.1023/A:1024461216994  0.32
1997 Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Annals of the New York Academy of Sciences. 836: 158-81. PMID 9616798  0.357
1997 Wasserman D, HellstrÖm C, Wasserman J, Beck O, Andersson E, Åsberg M. Natural killer cell activity and CSF monoamine metabolites in suicide attempters Archives of Suicide Research. 3: 153-169. DOI: 10.1023/A:1009675818287  0.433
1996 Nordström P, Gustavsson P, Edman G, Asberg M. Temperamental vulnerability and suicide risk after attempted suicide. Suicide & Life-Threatening Behavior. 26: 380-94. PMID 9014268 DOI: 10.1111/J.1943-278X.1996.Tb00842.X  0.473
1996 Ferrada-Noli M, Åsberg M, Ormstad K. Psychiatric care and transcultural factors in suicide incidence Nordic Journal of Psychiatry. 50: 21-25. DOI: 10.3109/08039489609081384  0.43
1995 Nordström P, Asberg M, Aberg-Wistedt A, Nordin C. Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatrica Scandinavica. 92: 345-50. PMID 8619338  0.356
1995 Ferrada-Noli M, Asberg M, Ormstad K, Nordström P. Definite and undetermined forensic diagnoses of suicide among immigrants in Sweden. Acta Psychiatrica Scandinavica. 91: 130-5. PMID 7778471  0.364
1995 Nordström P, Samuelsson M, Asberg M. Survival analysis of suicide risk after attempted suicide. Acta Psychiatrica Scandinavica. 91: 336-40. PMID 7639090 DOI: 10.1111/J.1600-0447.1995.Tb09791.X  0.452
1995 Nordström P, Schalling D, Asberg M. Temperamental vulnerability in attempted suicide. Acta Psychiatrica Scandinavica. 92: 155-60. PMID 7572263 DOI: 10.1111/J.1600-0447.1995.Tb09560.X  0.453
1994 Nordström P, Samuelsson M, Asberg M, Träskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide & Life-Threatening Behavior. 24: 1-9. PMID 7515519  0.648
1994 Runeson B, Wasserman D, Träskman-Bendz L, Ågren H, Åsberg M. Management of suicide attempters in psychiatric care in Sweden:Evaluation of a questionnaire to psychiatric care providers Nordic Journal of Psychiatry. 48: 117-120. DOI: 10.3109/08039489409078137  0.631
1992 Nordström P, Asberg M. Suicide risk and serotonin. International Clinical Psychopharmacology. 6: 12-21. PMID 1385514 DOI: 10.1097/00004850-199206006-00003  0.503
1991 Asberg M. [Suicide and biological markers]. Lã¤Kartidningen. 88: 743-6. PMID 2002742  0.34
1990 Rydin E, Asberg M, Edman G, Schalling D. Violent and nonviolent suicide attempts--a controlled Rorschach study. Acta Psychiatrica Scandinavica. 82: 30-9. PMID 2399818  0.339
1990 Bartfai A, Winborg IM, Nordström P, Asberg M. Suicidal behavior and cognitive flexibility: design and verbal fluency after attempted suicide. Suicide & Life-Threatening Behavior. 20: 254-66. PMID 2238017  0.302
1989 Traskman-Bendz L, Asberg M, Nordstrom P, Stanley M. Biochemical aspects of suicidal behavior. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: S35-44. PMID 2616793 DOI: 10.1016/0278-5846(89)90108-5  0.699
1987 Wägner A, Aberg-Wistedt A, Asberg M, Bertilsson L, MÃ¥rtensson B, Montero D. Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder. Archives of General Psychiatry. 44: 870-7. PMID 2821953 DOI: 10.1001/Archpsyc.1987.01800220032006  0.371
1986 Asberg M. Biochemical aspects of suicide. Clinical Neuropharmacology. 9: 374-6. PMID 3032431  0.37
1986 Asberg M, Eriksson B, MÃ¥rtensson B, Träskman-Bendz L, Wägner A. Therapeutic effects of serotonin uptake inhibitors in depression. The Journal of Clinical Psychiatry. 47: 23-35. PMID 2937776  0.592
1986 Asberg M, Nordström P, Träskman-Bendz L. Cerebrospinal fluid studies in suicide. An overview. Annals of the New York Academy of Sciences. 487: 243-55. PMID 2436537 DOI: 10.1111/J.1749-6632.1986.Tb27903.X  0.644
1986 Träskman-Bendz L, Asberg M, Schalling D. Serotonergic function and suicidal behavior in personality disorders. Annals of the New York Academy of Sciences. 487: 168-74. PMID 2436531 DOI: 10.1111/J.1749-6632.1986.Tb27896.X  0.612
1986 Edman G, Asberg M, Levander S, Schalling D. Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients. Archives of General Psychiatry. 43: 586-92. PMID 2423049 DOI: 10.1001/Archpsyc.1986.01800060080010  0.519
1985 Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L. Homicide, suicide and CSF 5-HIAA. Acta Psychiatrica Scandinavica. 71: 230-6. PMID 2580421  0.403
1984 Asberg M, Bertilsson L, MÃ¥rtensson B. CSF monoamine metabolites, depression, and suicide. Advances in Biochemical Psychopharmacology. 39: 87-97. PMID 6205566  0.414
1984 Träskman-Bendz L, Asberg M, Bertilsson L, Thorén P. CSF monoamine metabolites of depressed patients during illness and after recovery. Acta Psychiatrica Scandinavica. 69: 333-42. PMID 6202099  0.616
1984 Asberg M, Bertilsson L, MÃ¥rtensson B, Scalia-Tomba GP, Thorén P, Träskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica. 69: 201-19. PMID 6201041  0.588
1982 Rydin E, Schalling D, Asberg M. Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid. Psychiatry Research. 7: 229-43. PMID 6183703 DOI: 10.1016/0165-1781(92)90096-L  0.416
1982 Bertilsson L, Tybring G, Braithwaite R, Träskman-Bendz L, Asberg M. Urinary excretion of 5-hydroxyindoleacetic acid--no relationship to the level in cerebrospinal fluid. Acta Psychiatrica Scandinavica. 66: 190-8. PMID 6182758  0.56
1982 Bertilsson L, Asberg M, Lantto O, Scalia-Tomba GP, Träskman-Bendz L, Tybring G. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls. Psychiatry Research. 6: 77-83. PMID 6173891 DOI: 10.1016/0165-1781(82)90040-3  0.596
1981 Asberg M, Träskman L. Studies of CSF 5-HIAA in depression and suicidal behaviour. Advances in Experimental Medicine and Biology. 133: 739-52. PMID 6172023 DOI: 10.1007/978-1-4684-3860-4_41  0.424
1981 Träskman L, Asberg M, Bertilsson L, Sjöstrand L. Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry. 38: 631-6. PMID 6166274 DOI: 10.1001/Archpsyc.1981.01780310031002  0.567
1981 Träskman-Bendz L, Asberg M, Bertilsson L. Serotonin and noradrenaline uptake inhibitors in the treatment of depression--relationship to 5-HIAA in spinal fluid. Acta Psychiatrica Scandinavica. Supplementum. 290: 209-18. PMID 6164251  0.562
1981 Oreland L, Wiberg A, Asberg M, Träskman L, Sjöstrand L, Thorén P, Bertilsson L, Tybring G. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Research. 4: 21-9. PMID 6164071 DOI: 10.1016/0165-1781(81)90004-4  0.506
1981 Åsberg M, Varpila-Hansson R, Tomba P, Aminoff A, Mårtensson B, Thorén P, Träskman-Bendz L, Eneroth P, Åström G. Suicidal Behavior and the Dexamethasone Suppression Test American Journal of Psychiatry. 138: 994-995. DOI: 10.1176/Ajp.138.7.994  0.603
1980 Thorén P, Asberg M, Cronholm B, Jörnestedt L, Träskman L. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Archives of General Psychiatry. 37: 1281-5. PMID 7436690 DOI: 10.1001/Archpsyc.1980.01780240079009  0.326
1980 Sjöqvist F, Bertilsson L, Asberg M. Monitoring tricyclic antidepressants. Therapeutic Drug Monitoring. 2: 85-93. PMID 6762705 DOI: 10.1097/00007691-198001000-00010  0.341
1980 Thorén P, Asberg M, Bertilsson L, Mellström B, Sjöqvist F, Träskman L. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. Archives of General Psychiatry. 37: 1289-94. PMID 6159865 DOI: 10.1001/Archpsyc.1980.01780240087010  0.37
1980 Träskman L, Tybring G, Asberg M, Bertilsson L, Lantto O, Schalling D. Cortisol in the CSF of depressed and suicidal patients. Archives of General Psychiatry. 37: 761-7. PMID 6156664 DOI: 10.1001/Archpsyc.1980.01780200039004  0.466
1979 Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry : the Journal of Mental Science. 134: 382-9. PMID 444788 DOI: 10.1192/Bjp.134.4.382  0.349
1978 Montgomery S, Cronholm B, Asberg M, Montgomery DB. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline. British Journal of Clinical Pharmacology. 5: 77S-80S. PMID 341948  0.334
1977 Cronholm B, Asberg M, Montgomery S, Schalling D. Suicidal behaviour syndrome with low CSF 5-HIAA. British Medical Journal. 1: 776. PMID 851730  0.314
1976 Asberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Archives of General Psychiatry. 33: 1193-7. PMID 971028 DOI: 10.1001/Archpsyc.1976.01770100055005  0.478
1974 Cronholm B, Schalling D, Asberg M. Development of a rating scale for depressive illness. Modern Problems of Pharmacopsychiatry. 7: 139-50. PMID 4412781 DOI: 10.1159/000395073  0.346
1973 Asberg M, Bertilsson L, Tuck D, Cronholm B, Sjöqvist F. Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clinical Pharmacology and Therapeutics. 14: 277-86. PMID 4695388  0.313
1972 Asberg M, Bertilsson L, Cronholm B, Härfast A, Sjöqvist F, Tuck D. [Studies of indolamine metabolites in cerebrospinal fluid in depression]. Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry. 26: 351-7. PMID 4634570 DOI: 10.3109/08039487209092077  0.394
Show low-probability matches.